Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

An oxidation-resistant, recombinant alpha-1 antitrypsin produced in Nicotiana benthamiana.

Silberstein DZ, Karuppanan K, Aung HH, Chen CH, Cross CE, McDonald KA.

Free Radic Biol Med. 2018 May 20;120:303-310. doi: 10.1016/j.freeradbiomed.2018.03.015. Epub 2018 Mar 16.

2.
3.

Agonist-specific patterns of beta 2-adrenoceptor responses in human airway cells during prolonged exposure.

Düringer C, Grundström G, Gürcan E, Dainty IA, Lawson M, Korn SH, Jerre A, Håkansson HF, Wieslander E, Fredriksson K, Sköld CM, Löfdahl M, Löfdahl CG, Nicholls DJ, Silberstein DS.

Br J Pharmacol. 2009 Sep;158(1):169-79. doi: 10.1111/j.1476-5381.2009.00262.x. Epub 2009 Jun 22.

4.

Irregular respiration as a marker of wakefulness during titration of CPAP.

Ayappa I, Norman RG, Whiting D, Tsai AH, Anderson F, Donnely E, Silberstein DJ, Rapoport DM.

Sleep. 2009 Jan;32(1):99-104.

5.

Sensitivity of disease parameters to flexible budesonide/formoterol treatment in an allergic rat model.

Brange C, Smailagic A, Jansson AH, Middleton B, Miller-Larsson A, Taylor JD, Silberstein DS, Lal H.

Pulm Pharmacol Ther. 2009 Feb;22(1):20-6. doi: 10.1016/j.pupt.2008.10.011. Epub 2008 Nov 12.

PMID:
19041412
6.

The transition to oral feeding in low-risk premature infants: relation to infant neurobehavioral functioning and mother-infant feeding interaction.

Silberstein D, Geva R, Feldman R, Gardner JM, Karmel BZ, Rozen H, Kuint J.

Early Hum Dev. 2009 Mar;85(3):157-62. doi: 10.1016/j.earlhumdev.2008.07.006. Epub 2008 Sep 21.

PMID:
18809266
7.

Differences in endogenous esterification and retention in the rat trachea between budesonide and ciclesonide active metabolite.

Lexmüller K, Gullstrand H, Axelsson BO, Sjölin P, Korn SH, Silberstein DS, Miller-Larsson A.

Drug Metab Dispos. 2007 Oct;35(10):1788-96. Epub 2007 Jul 12.

PMID:
17627977
8.

Kinetics of gene expression in murine cutaneous graft-versus-host disease.

Sugerman PB, Faber SB, Willis LM, Petrovic A, Murphy GF, Pappo J, Silberstein D, van den Brink MR.

Am J Pathol. 2004 Jun;164(6):2189-202.

9.

Ges, A human GTPase of the Rad/Gem/Kir family, promotes endothelial cell sprouting and cytoskeleton reorganization.

Pan JY, Fieles WE, White AM, Egerton MM, Silberstein DS.

J Cell Biol. 2000 May 29;149(5):1107-16. Erratum in: J Cell Biol 2000 Jul 24;150(2):following 401.

10.

Orally active trifluoromethyl ketone inhibitors of human leukocyte elastase.

Veale CA, Bernstein PR, Bohnert CM, Brown FJ, Bryant C, Damewood JR Jr, Earley R, Feeney SW, Edwards PD, Gomes B, Hulsizer JM, Kosmider BJ, Krell RD, Moore G, Salcedo TW, Shaw A, Silberstein DS, Steelman GB, Stein M, Strimpler A, Thomas RM, Vacek EP, Williams JC, Wolanin DJ, Woolson S.

J Med Chem. 1997 Sep 26;40(20):3173-81.

PMID:
9379436
11.

Eosinophil function in health and disease.

Silberstein DS.

Crit Rev Oncol Hematol. 1995 Apr;19(1):47-77. Review. No abstract available.

PMID:
7741980
12.

Opposing regulatory effects of thioredoxin and eosinophil cytotoxicity-enhancing factor on the development of human immunodeficiency virus 1.

Newman GW, Balcewicz-Sablinska MK, Guarnaccia JR, Remold HG, Silberstein DS.

J Exp Med. 1994 Jul 1;180(1):359-63.

13.
14.

IL-10 induces transcription of the gene for mouse mast cell protease-1, a serine protease preferentially expressed in mucosal mast cells of Trichinella spiralis-infected mice.

Ghildyal N, McNeil HP, Stechschulte S, Austen KF, Silberstein D, Gurish MF, Somerville LL, Stevens RL.

J Immunol. 1992 Sep 15;149(6):2123-9.

PMID:
1517575
15.

Stimulation of ovarian tumor cell proliferation with monocyte products including interleukin-1, interleukin-6, and tumor necrosis factor-alpha.

Wu S, Rodabaugh K, Martinez-Maza O, Watson JM, Silberstein DS, Boyer CM, Peters WP, Weinberg JB, Berek JS, Bast RC Jr.

Am J Obstet Gynecol. 1992 Mar;166(3):997-1007.

PMID:
1550178
16.

Identification of C3 beta chain as the human serum eosinophil cytotoxicity inhibitor.

Minkoff MS, Wong WW, Silberstein DS.

J Exp Med. 1991 Nov 1;174(5):1267-70.

17.
18.

Human eosinophils express functional interleukin 2 receptors.

Rand TH, Silberstein DS, Kornfeld H, Weller PF.

J Clin Invest. 1991 Sep;88(3):825-32.

19.

DF3 antigen, a human epithelial cell mucin, inhibits adhesion of eosinophils to antibody-coated targets.

Hayes DF, Silberstein DS, Rodrique SW, Kufe DW.

J Immunol. 1990 Aug 1;145(3):962-70.

PMID:
2373864
20.

A mechanism of D-(+)-sotalol effects on heart rate not related to beta-adrenoceptor antagonism.

Funck-Brentano C, Silberstein DJ, Roden DM, Wood AJ, Woosley RL.

Br J Clin Pharmacol. 1990 Aug;30(2):195-202.

21.

Trichinella spiralis: secreted antigen of the infective L1 larva localizes to the cytoplasm and nucleoplasm of infected host cells.

Despommier DD, Gold AM, Buck SW, Capo V, Silberstein D.

Exp Parasitol. 1990 Jul;71(1):27-38.

PMID:
2354715
22.
23.

The role of genetically determined polymorphic drug metabolism in the beta-blockade produced by propafenone.

Lee JT, Kroemer HK, Silberstein DJ, Funck-Brentano C, Lineberry MD, Wood AJ, Roden DM, Woosley RL.

N Engl J Med. 1990 Jun 21;322(25):1764-8.

24.

The ability of mouse monoclonal antibodies to direct the cytotoxic function of cytokine-activated human eosinophils.

Silberstein DS, David JR, Harn DA.

Hybridoma. 1990 Jun;9(3):237-42. No abstract available.

PMID:
2194934
25.

Inhibition of IgG-triggered human eosinophil function by IL-4.

Baskar P, Silberstein DS, Pincus SH.

J Immunol. 1990 Mar 15;144(6):2321-6.

PMID:
2138196
26.

A serum factor that suppresses the cytotoxic function of cytokine-stimulated human eosinophils.

Silberstein DS, Minkoff MS, Creasey AA, David JR.

J Exp Med. 1990 Mar 1;171(3):681-93.

27.
28.

Hemopoietins for eosinophils. Glycoprotein hormones that regulate the development of inflammation in eosinophilia-associated disease.

Silberstein DS, Austen KF, Owen WF Jr.

Hematol Oncol Clin North Am. 1989 Sep;3(3):511-33. Review.

PMID:
2698880
29.

Human eosinophil cytotoxicity-enhancing factor. Purification, physical characteristics, and partial amino acid sequence of an active polypeptide.

Silberstein DS, Ali MH, Baker SL, David JR.

J Immunol. 1989 Aug 1;143(3):979-83. Erratum in: J Immunol 1991 Dec 15;147(12):4408.

PMID:
2745979
30.

Interleukin 5 and phenotypically altered eosinophils in the blood of patients with the idiopathic hypereosinophilic syndrome.

Owen WF, Rothenberg ME, Petersen J, Weller PF, Silberstein D, Sheffer AL, Stevens RL, Soberman RJ, Austen KF.

J Exp Med. 1989 Jul 1;170(1):343-8.

31.

Interindividual differences in beta-receptor density contribute to variability in response to beta-adrenoceptor antagonists.

Zhou HH, Silberstein DJ, Koshakji RP, Wood AJ.

Clin Pharmacol Ther. 1989 Jun;45(6):587-92.

PMID:
2543534
32.

Stereoselective disposition and pharmacologic activity of propafenone enantiomers.

Kroemer HK, Funck-Brentano C, Silberstein DJ, Wood AJ, Eichelbaum M, Woosley RL, Roden DM.

Circulation. 1989 May;79(5):1068-76.

PMID:
2713973
33.

Activation of eosinophils in cancer patients treated with IL-2 and IL-2-generated lymphokine-activated killer cells.

Silberstein DS, Schoof DD, Rodrick ML, Tai PC, Spry CJ, David JR, Eberlein TJ.

J Immunol. 1989 Mar 15;142(6):2162-7.

PMID:
2784151
34.

Racial differences in drug response. Altered sensitivity to and clearance of propranolol in men of Chinese descent as compared with American whites.

Zhou HH, Koshakji RP, Silberstein DJ, Wilkinson GR, Wood AJ.

N Engl J Med. 1989 Mar 2;320(9):565-70.

PMID:
2536896
35.

Altered beta-adrenoceptor internalization does not explain reduced beta-adrenergic responsiveness in the elderly.

Silberstein DJ, Rigby J, Merrell J, Naslund T, Wood AJ.

J Clin Endocrinol Metab. 1989 Jan;68(1):131-4.

PMID:
2562842
36.
37.

Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3.

Rothenberg ME, Owen WF Jr, Silberstein DS, Woods J, Soberman RJ, Austen KF, Stevens RL.

J Clin Invest. 1988 Jun;81(6):1986-92.

38.

Eosinophils cocultured with endothelial cells have increased survival and functional properties.

Rothenberg ME, Owen WF Jr, Silberstein DS, Soberman RJ, Austen KF, Stevens RL.

Science. 1987 Aug 7;237(4815):645-7.

PMID:
3110954
39.

Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts.

Owen WF Jr, Rothenberg ME, Silberstein DS, Gasson JC, Stevens RL, Austen KF, Soberman RJ.

J Exp Med. 1987 Jul 1;166(1):129-41.

40.

Characterization of a factor from the U937 cell line that enhances the toxicity of human eosinophils to Schistosoma mansoni larvae.

Silberstein DS, Dessein AJ, Elsas PP, Fontaine B, David JR.

J Immunol. 1987 May 1;138(9):3042-50.

PMID:
3494778
41.

Pharmacokinetics and biliary excretion of rose bengal in rats with acute and chronic renal failure.

Silberstein DJ, Bowmer CJ, Yates MS.

J Pharm Pharmacol. 1987 May;39(5):395-8.

PMID:
2886591
42.

The effect of adherent cell-derived factors on immunoglobulin and anti-DNA synthesis in systemic lupus erythematosus.

Jandl RC, George JL, Silberstein DS, Eaton RB, Schur PH.

Clin Immunol Immunopathol. 1987 Mar;42(3):344-59.

PMID:
3493867
43.

The regulation of human eosinophil function by cytokines.

Silberstein DS, David JR.

Immunol Today. 1987;8(12):380-5. doi: 10.1016/0167-5699(87)90214-3.

PMID:
25291273
44.
45.

Enhancement of human eosinophil cytotoxicity and leukotriene synthesis by biosynthetic (recombinant) granulocyte-macrophage colony-stimulating factor.

Silberstein DS, Owen WF, Gasson JC, DiPersio JF, Golde DW, Bina JC, Soberman R, Austen KF, David JR.

J Immunol. 1986 Nov 15;137(10):3290-4.

PMID:
3095427
46.

Effect of acute renal failure on the disposition and elimination of [3H]N-acetyl procainamide ethobromide in the rat.

Silberstein DJ, Bowmer CJ, Yates MS, Dean HG.

J Pharm Pharmacol. 1986 Sep;38(9):679-85.

PMID:
2430089
47.

Enhancement by monokines of leukotriene generation by human eosinophils and neutrophils stimulated with calcium ionophore A23187.

Dessein AJ, Lee TH, Elsas P, Ravalese J 3rd, Silberstein D, David JR, Austen KF, Lewis RA.

J Immunol. 1986 May 15;136(10):3829-38.

PMID:
3009610
48.

Tumor necrosis factor enhances eosinophil toxicity to Schistosoma mansoni larvae.

Silberstein DS, David JR.

Proc Natl Acad Sci U S A. 1986 Feb;83(4):1055-9.

49.

Immunization with purified antigens protects mice from lethal infection with Trichinella spiralis.

Silberstein DS, Despommier DD.

J Parasitol. 1985 Aug;71(4):516-7. No abstract available.

PMID:
4032155
50.

Effects on Trichinella spiralis of host responses to purified antigens.

Silberstein DS, Despommier DD.

Science. 1985 Feb 22;227(4689):948-50.

PMID:
3969571

Supplemental Content

Loading ...
Support Center